Filing Flows › Eton Pharmaceuticals (ETON) › Capital expenditures
Eton Pharmaceuticals (ETON) capital expenditures by quarter
Eton Pharmaceuticals' capital expenditures were $13K in Q3 2026 (third quarter 2026), -83% from Q1 2026. Over the last 3 quarters it ranged from $13K (Q3 2026) to $284K (Q3 2025).
| Quarter | Capital expenditures | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $13K | -83% | -95% |
| Q1 2026 | $75K | -74% | — |
| Q3 2025 | $284K | — | — |
Q3 2026 at a glance
Eton Pharmaceuticals, Q3 2026: revenue $57.9M (+158% year over year), operating margin 39.7%, net earnings $35.2M, operating cash flow $35.2M. The chart follows the revenue to costs, profit and cash.
Questions
What is Eton Pharmaceuticals' capital expenditures?
Eton Pharmaceuticals' capital expenditures were $13K in Q3 2026 (third quarter 2026), -83% from Q1 2026.
How has Eton Pharmaceuticals' capital expenditures changed?
Over the last 3 quarters it ranged from $13K (Q3 2026) to $284K (Q3 2025).